Alexandria Real Estate Equities ARE posted third-quarter results that were roughly in line with our expectations, so our fair value estimate is unchanged. Total revenue for this life science property owner inched up 1.8% over the comparable quarter in 2008. Granted, part of this bump was due to property deliveries done in late 2008 and 2009. Still, we're quite impressed, as year-over-year same-property net operating income margins actually increased 0.8%, thanks to revenue increasing 1.1%. Though same-property occupancy trended down to 94.1% from 95.3% a year ago, we believe that figure is still decent and demonstrates the resiliency of Alexandria's diversified portfolio of life science real estate.
Get our full take on
Alexandria Real Estate Equities, Inc.
See our complete company report and outlook--including fair value estimate, consider buying and selling prices, risk rating, bull and bear arguments,
and star rating--with a free two-week Morningstar.com Premium Membership trial.
You will also get complete access to all 2,000 Stock Analyst Reports, 2,000 Mutual Fund Analyst Reports, and Morningstar's award-winning Portfolio Management and Screening tools.
Start my free trial Learn more about Premium Membership View Sample Analyst Report
More Analyst Research
Alexandria Real Estate Equities, Inc. Full Analyst Report
Analyst Notes 09-25-09 | 9:13AM Alexandria Issues Again 08-28-09 | 12:08PM Reduced Uncertainty for Alexandria 08-06-09 | 5:04PM Alexandria Posts Positive 2Q 05-08-09 | 4:51PM Alexandria Posts Stable 1Q Results
|